Literature DB >> 21336842

Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle.

Cristoforo Silvestri1, Alessia Ligresti, Vincenzo Di Marzo.   

Abstract

The endocannabinoid system (ECS) is composed of lipid signalling ligands, their G-protein coupled receptors and the enzymes involved in ligand generation and metabolism. Increasingly, the ECS is emerging as a critical agent of energy metabolism regulation through its ability to modulate caloric intake centrally as well as nutrient transport, cellular metabolism and energy storage peripherally. Visceral obesity has been associated with an upregulation of ECS activity in several systems and inhibition of the ECS, either pharmacologically or genetically, results in decreased energy intake and increased metabolic output. This review aims to summarize the recent advances that have been made regarding our understanding of the role the ECS plays in crucial peripheral systems pertaining to energy homeostasis: adipose tissues, the liver and skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336842     DOI: 10.1007/s11154-011-9167-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  87 in total

1.  Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin.

Authors:  N Perwitz; M Fasshauer; J Klein
Journal:  Horm Metab Res       Date:  2006-05       Impact factor: 2.936

2.  Effects of cannabinoid receptors on skeletal muscle oxidative pathways.

Authors:  P Cavuoto; A J McAinch; G Hatzinikolas; D Cameron-Smith; G A Wittert
Journal:  Mol Cell Endocrinol       Date:  2006-12-21       Impact factor: 4.102

3.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Authors:  Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; George Kunos
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

Authors:  J Agudo; M Martin; C Roca; M Molas; A S Bura; A Zimmer; F Bosch; R Maldonado
Journal:  Diabetologia       Date:  2010-09-11       Impact factor: 10.122

5.  Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier.

Authors:  Jean-Marie Receveur; Anthony Murray; Jean-Michel Linget; Pia K Nørregaard; Martin Cooper; Emelie Bjurling; Peter Aadal Nielsen; Thomas Högberg
Journal:  Bioorg Med Chem Lett       Date:  2009-12-04       Impact factor: 2.823

6.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

7.  Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.

Authors:  Won-il Jeong; Douglas Osei-Hyiaman; Ogyi Park; Jie Liu; Sándor Bátkai; Partha Mukhopadhyay; Norio Horiguchi; Judith Harvey-White; Giovanni Marsicano; Beat Lutz; Bin Gao; George Kunos
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

Review 8.  The role of the lipogenic pathway in the development of hepatic steatosis.

Authors:  C Postic; J Girard
Journal:  Diabetes Metab       Date:  2008-12       Impact factor: 6.041

9.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

10.  Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.

Authors:  Ruben Nogueiras; Christelle Veyrat-Durebex; Paula M Suchanek; Marcella Klein; Johannes Tschöp; Charles Caldwell; Stephen C Woods; Gabor Wittmann; Masahiko Watanabe; Zsolt Liposits; Csaba Fekete; Ofer Reizes; Francoise Rohner-Jeanrenaud; Matthias H Tschöp
Journal:  Diabetes       Date:  2008-08-20       Impact factor: 9.461

View more
  27 in total

Review 1.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

2.  Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Sándor Bátkai; Malek Kechrid; Partha Mukhopadhyay; Wen-Shin Lee; Béla Horváth; Eileen Holovac; Resat Cinar; Lucas Liaudet; Ken Mackie; György Haskó; Pál Pacher
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

Review 3.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

4.  Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop.

Authors:  Andrea Martella; Cristoforo Silvestri; Francesca Maradonna; Giorgia Gioacchini; Marco Allarà; Giuseppe Radaelli; Darryl R Overby; Vincenzo Di Marzo; Oliana Carnevali
Journal:  Endocrinology       Date:  2016-03-25       Impact factor: 4.736

Review 5.  New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism.

Authors:  L Cristino; L Palomba; V Di Marzo
Journal:  Int J Obes Suppl       Date:  2014-07-08

Review 6.  Role of the endocannabinoid system in diabetes and diabetic complications.

Authors:  G Gruden; F Barutta; G Kunos; P Pacher
Journal:  Br J Pharmacol       Date:  2015-08-20       Impact factor: 8.739

7.  Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primates.

Authors:  Vidya Vaidyanathan; Raul A Bastarrachea; Paul B Higgins; V Saroja Voruganti; Subhash Kamath; Nicholas V DiPatrizio; Daniele Piomelli; Anthony G Comuzzie; Elizabeth J Parks
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

Review 8.  Novel aspects of brown adipose tissue biology.

Authors:  Joerg Heeren; Heike Münzberg
Journal:  Endocrinol Metab Clin North Am       Date:  2012-12-12       Impact factor: 4.741

9.  Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity.

Authors:  François-Xavier Gamelin; Julien Aucouturier; Fabio Arturo Iannotti; Fabiana Piscitelli; Enrico Mazzarella; Teresa Aveta; Melissa Leriche; Erwan Dupont; Caroline Cieniewski-Bernard; Valérie Montel; Bruno Bastide; Vincenzo Di Marzo; Elsa Heyman
Journal:  J Physiol Biochem       Date:  2016-02-15       Impact factor: 4.158

Review 10.  Principles of motivation revealed by the diverse functions of neuropharmacological and neuroanatomical substrates underlying feeding behavior.

Authors:  Brian A Baldo; Wayne E Pratt; Matthew J Will; Erin C Hanlon; Vaishali P Bakshi; Martine Cador
Journal:  Neurosci Biobehav Rev       Date:  2013-03-01       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.